Back
Salesforce, Inc. Vs. GeneDx Holdings Corp. Industry Stock Comparison
Buy
59
CRM
Salesforce, Inc.
Last Price:
$262.23
Seasonality Move:
6.5%
Buy
58
WGS
GeneDx Holdings Corp.
Last Price:
$151.31
Seasonality Move:
109.52%
Buy
59
Salesforce, Inc. (CRM)
is a Buy
Is Salesforce, Inc. a Buy, Sell or Hold?
-
The current Salesforce, Inc. [CRM] share price is $262.23. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
GeneDx Holdings Corp. (WGS)
is a Buy
Is GeneDx Holdings Corp. a Buy, Sell or Hold?
-
The current GeneDx Holdings Corp. [WGS] share price is $155.37. The Score for WGS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
WGS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRM Stock Price Chart
What is Salesforce, Inc.'s stock price today?
-
The Salesforce, Inc. share price today is $262.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing slight selling pressure.
WGS Stock Price Chart
What is GeneDx Holdings Corp.'s stock price today?
-
The GeneDx Holdings Corp. share price today is $155.37The current trend is moderately bullish and WGS is experiencing slight selling pressure.
CRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.23 | Buy |
| Relative Strength Index (14 RSI): | 65.58 | Buy |
| Chaikin Money Flow: | -1577146 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (229.44 - 254.58) | Buy |
| Bollinger Bands (100): | (236.49 - 256.79) | Buy |
WGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 27.35 | Buy |
| Relative Strength Index (14 RSI): | 56.59 | Buy |
| Chaikin Money Flow: | 57477 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 257.01 | Buy |
| 20-day SMA: | 241.89 | Buy |
| 50-day SMA: | 245.76 | Buy |
| 200-day SMA: | 258.37 | Buy |
| 8-day EMA: | 256.43 | Buy |
| 20-day EMA: | 248.56 | Buy |
| 50-day EMA: | 246.36 | Buy |
| 200-day EMA: | 258.9 | Buy |
WGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 159.56 | Sell |
| 20-day SMA: | 151.52 | Buy |
| 50-day SMA: | 137.63 | Buy |
| 200-day SMA: | 105.24 | Buy |
| 8-day EMA: | 157.91 | Sell |
| 20-day EMA: | 138.63 | Buy |
| 50-day EMA: | 89.48 | Buy |
| 200-day EMA: | 29.82 | Buy |
Salesforce, Inc. Earnings Growth & CRM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.20 per share, an increase this year of $1.83 per share, and an increase next year of $1.74 per share.
GeneDx Holdings Corp. Earnings Growth & WGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.73 per share, and a decrease next year of $0.95 per share.
Salesforce, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
GeneDx Holdings Corp. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||